GOLPH3 and COVID-19: Nonetheless, pathological elevation of blood glucose in moderate and severe COVID-19 patients has been linked to enhanced hepatic gluconeogenesis by the activity of the Golgi protein GP73, which is found to be elevated in the plasma of infected patients37.